News

A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer

7/17/2025

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

New Study: Providence whole genome sequencing program shows transformative potential for population health

7/1/2025

Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.

Cancer patients in Newberg receive a gift of comfort

6/19/2025

A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.

New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

5/28/2025

Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

Providence researchers share cancer discoveries at 2025 ASCO meeting

5/29/2025

Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

5/29/2025

Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

Renovations Complete at Portland’s Busiest Emergency Department

5/20/2025

A $47 million renovation of the emergency department at Providence St. Vincent Medical Center has transformed Portland’s busiest emergency department into a state-of-the-art space.

Clinical trials matter, just ask Randy

5/19/2025

When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.